Patents by Inventor Sean Salmon

Sean Salmon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240065757
    Abstract: Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 29, 2024
    Inventors: Douglas A. Hettrick, Julie Trudel, Paul Coates, Robert J. Melder, Stefan S. Tunev, Martin Rothman, Sean Salmon
  • Patent number: 11844568
    Abstract: Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: December 19, 2023
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Douglas A. Hettrick, Julie Trudel, Paul Coates, Robert J. Melder, Stefan S. Tunev, Martin Rothman, Sean Salmon
  • Publication number: 20220226042
    Abstract: Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 21, 2022
    Inventors: Douglas A. Hettrick, Julie Trudel, Paul Coates, Robert J. Melder, Stefan S. Tunev, Martin Rothman, Sean Salmon
  • Patent number: 11304749
    Abstract: Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: April 19, 2022
    Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
    Inventors: Douglas A. Hettrick, Julie Trudel, Paul Coates, Robert J. Melder, Stefan S. Tunev, Martin Rothman, Sean Salmon
  • Publication number: 20190151013
    Abstract: Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.
    Type: Application
    Filed: November 14, 2018
    Publication date: May 23, 2019
    Inventors: Douglas A. Hettrick, Julie Trudel, Paul Coates, Robert J. Melder, Stefan S. Tunev, Martin Rothman, Sean Salmon
  • Patent number: 7037327
    Abstract: A hybrid stent that is defined as having a central section that is balloon expandable and end sections that are self-expanding. The entire stent is mounted on a balloon of a balloon angioplasty catheter. One way to retain the self-expanding portion of the stent onto a balloon onto which it has been nested is to place a cylindrical elastomer tube around each of the self-expanding end sections of the stent.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: May 2, 2006
    Inventors: Sean Salmon, Dieter Stockel, Robert E. Fischell, Tim A. Fischell, David R. Fischell
  • Publication number: 20020007102
    Abstract: The present invention is a hybrid stent that is defined as having a central section that is balloon expandable and end sections that are self-expanding. The entire stent is mounted on a balloon of a balloon angioplasty catheter. One way to retain the self-expanding portion of the stent onto a balloon onto which it has been nested is to place a cylindrical elastomer tube around each of the self-expanding end sections of the stent.
    Type: Application
    Filed: September 24, 2001
    Publication date: January 17, 2002
    Inventors: Sean Salmon, Dieter Stockel, Robert E. Fischell, Tim A. Fischell, David R. Fischell
  • Patent number: 6315708
    Abstract: The present invention is a hybrid stent that is defined as having a central section that is balloon expandable and end sections that are self-expanding. The entire stent is mounted on a balloon of a balloon angioplasty catheter. One way to retain the self-expanding portion of the stent onto a balloon onto which it has been nested is to place a cylindrical elastomer tube around each of the self-expanding end sections of the stent.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: November 13, 2001
    Assignee: Cordis Corporation
    Inventors: Sean Salmon, Dieter Stockel, Robert E. Fischell, Tim A. Fischell, David R. Fischell